NANOG and invasive breast carcinoma: We designed this study to evaluate the expression of ESC transcription factors (Oct4, Sox2, Nanog, Bmi1, and Klf4) in human invasive breast cancer samples, and to analyze their association with the clinicopathologic features of tumors including BCSC phenotype, EMT marker expression, molecular subtype, and prognosis.